The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “February 2019” and All Insider Sales to “$5,000,000+.”
According to these filters, the following are trades from company insiders this week.
Part owners MPM BioVentures 2014 L.P., the Oncology Impact Fund (Cayman), Upnorth Investment Ltd and directors Morana Jovan-Embiricos and Ansbert Gadicke, bought a combined 4,319,999 shares of TCR2 Therapeutics Inc. (TCRR) for an average price of $15 per share on Feb. 19.
The biotechnology company has a market cap of $350.86 million, an enterprise value of $219.86 million and an insider ownership of 0.31%.
Redmile Group LLC, 10% owner of Xeris Pharmaceuticals Inc. (XERS, Financial), bought 588,000 shares for an average price of $10 per share on Feb. 19.
The pharmaceutical company has a market cap of $201.41 million, an enterprise value of $102.02 million, an institutional ownership of 81.02% and insider ownership of 3.30%.
Over the last 12 months, the stock has fallen 52%.
Winder Investment Pte. Ltd., 10% owner of International Flavors & Fragrances Inc. (IFF, Financial), bought 50,000 shares for an average price of $129.04 per share on Feb. 19.
The company, which manufactures flavors and fragrances for a number of industries, has a market cap of $13.73 billion and an enterprise value of $17.63 billion. It has an institutional ownership of 112.70% and insider ownership of 1.33%.
Over the last 12 months, the stock has fallen 12% and, as of Friday, is trading 14.50% below its 52-week high and 5.43% above its 52-week low.
Alexandre Macedo, president of Tim Hortons, bought 45,000 shares of Restaurant Brands International Inc. (QSR) for an average price of $64.73 per share on Feb. 19.
The quick-service restaurant company has a market cap of $16.35 billion and an enterprise value of $29.68 billion. It has an institutional ownership of 111.38% and insider ownership of 0.83%.
Over the last 12 months, the stock has risen 9% and is currently trading 1.28% below its 52-week high and 28.98% above its 52-week low.
Most important insider sales
VenBio Select Advisor LLC, 10% owner of Mirati Therapeutics Inc. (MRTX, Financial), sold 686,820 shares for an average price of $73 per share on Feb. 20.
The company, which develops precision medicine for oncology therapeutics, has a $2.46 billion market cap and an enterprise value of $2.21 billion. It has an institutional ownership of 145.21% and insider ownership of 0.71%.
Over the last 12 months, the stock has climbed 163% and is currently trading 0.61% below its 52-week high and 206.45% above its 52-week low.
Sageview Capital Partners, Warburg Pincus & Co. and Director Edward A. Gilhuly sold a combined 13,210,000 shares of Avalara Inc. (AVLR) for an average price of $47.84 per share on Feb. 19 and 20.
The software company has a market cap of $3.35 billion and an enterprise value of $3.2 billion. It has an institutional ownership of 86.99% and insider ownership of 6.24%.
Over the last 12 months, the stock has risen 12%.
Disclosure: I do not own any stocks mentioned in this article.
Read more here:
